Extracorporeal photopheresis and multimodality therapy in patients with T‐cell cutaneous lymphomas: Real‐life experience in Argentina
Journal of Clinical Apheresis2021Vol. 36(6), pp. 815–822
Citations Over Time
Jenny Andrea Baquero Rey, Evelyn Andrea Zambrano Franco, Andrea Andrade Miranda, Sebastián Marciano, Luis Daniel Mazzuoccolo, Paula Enz
Abstract
Most patients with SS and MF who underwent multimodality therapy with ECP had favorable cutaneous and blood response. It is safe to combine ECP with other treatments. Studies with large numbers of patients are necessary to assess the effects of ECP on patient survival.
Related Papers
- → Photopheresis in the treatment of cutaneous T-cell lymphoma(2011)25 cited
- → Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome(2015)39 cited
- → Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T‐cell lymphoma(2023)2 cited
- → Photopheresis ? Extracorporeal irradiation of 8-MOP containing blood ? A new therapeutic modality(1987)22 cited
- → Photopheresis in the treatment of cutaneous T-cell lymphoma(2012)1 cited